more a natural progression from getting FDA IND clearance on 20 August. Less than two weeks on, and we’ve finalised a collaboration to accelerate our phase 1 trial recruitment and making meaningful inroads into preparing for our phase 2 trial.
I personally like to focus on what the business is doing as opposed to the share price. Does a company enter into a collaboration like this to speed up recruitment if they have seen bad results thus far, or is it more likely they have they seen something (or lack of something) to give them confidence to proceed aggressively.
- Forums
- ASX - By Stock
- Ann: Partnership with OncoBay Clinical to advance CHM 1101
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

more a natural progression from getting FDA IND clearance on 20...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $11.76K | 2.928M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 4817793 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18563373 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 4817793 | 0.004 |
40 | 27029271 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18563373 | 21 |
0.006 | 13384684 | 15 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2390797 | 5 |
Last trade - 14.13pm 26/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online